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Abstract: The North Wales Cancer Treatment Centre (NWCTC) has to deal with an   increasing 
demand in the number of patients who require chemotherapy, with the escalating use of second 
line, third line, and additional treatment for many cancers. As a result, there is growing   pressure on 
the chemotherapy unit to deliver treatment quickly, efficiently, and safely. Following   guidelines 
from the Department of Health’s Manual for Cancer Services, we are constantly looking for ways 
to improve and develop the level of care provided at our center, and the process of receiving 
chemotherapy has been identified as an area of high risk. Therefore, a team was established to 
review and explore current practices at the NWCTC with the goal of implementing an improved 
process to minimize the risks of chemotherapy treatment.
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Introduction
Each day more than one million people are safely and successfully treated at the 
National Health Service (NHS), but evidence suggests that errors occur in complex 
health care systems resulting in the risk of harming patients. Once patients enter the 
system, they have the right to expect that every effort is made to ensure that their care 
and treatment are both safe and effective. Everyone who works at the NHS contributes 
to the system that delivers health care, whether they hold a direct clinical or nonclini-
cal position.
Health care systems that continue to use processes that do not work cause 
delays in the system and result in high levels of error, and it is widely recognized 
that these processes need radical redesign. Therefore, patient safety is everybody’s 
responsibility.1
Background
The North Wales Cancer Centre opened in 2000, and the chemotherapy day unit now 
performs an average of 500 cycles of chemotherapy per month. Following   discussions 
at the Divisional Risk Management meeting, it was decided that a group was required 
to analyze the complexities of the chemotherapy process and ensure that all patients 
receive treatment specific to their diagnosis and with minimal complications within 
a reasonable period of time. A professional Chemotherapy Improvement Group was 
established comprising nurses, pharmacists, social workers, ward sisters,   dieticians, 
consultants, and patients. The Chemotherapy Improvement Group   meetings were 
initially scheduled every two weeks and later every month for a period of 18 months.2,3 Risk Management and Healthcare Policy 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
42
Garcia-Alonso
The aim of these meetings was to work effectively as a team 
and to   understand not just one’s own speciality, but to gain 
insight into other areas of expertise, which would, in turn, 
help the North Wales Cancer Treatment Centre run more 
efficiently and effectively.
The group was created to review and explore current 
  practices and to identify areas of risk during the   chemotherapy 
treatment of patients with cancer. The goal was to implement 
and improve the process for all concerned.
We recognize that the chemotherapy process carries a 
particularly high degree of risk. Therefore, we established 
an objective to improve patient care during chemotherapy 
treatment through the improvement of communication 
between the clinical areas, pharmacy, nursing staff, and 
clinical staff.
This analysis was planned as an audit of the process of 
chemotherapy treatment of cancer patients to provide a clear 
map of the pathway followed by patients on treatment and 
to address potential risk factors during the process. At the 
same time this study is a pioneer for larger studies looking 
into different issues and insights regarding risk management 
science in this patient population.
Starting point
We examined a patient’s journey from the original referral 
through to the first consultation with the consultant clinical 
oncologist and throughout the rest of the chemotherapy 
treatment.
The Chemotherapy Improvement Group reviewed the 
service and targeted specific areas for improvement by adopt-
ing a modernization approach. The team chose the tool of 
process mapping, and several sessions were undertaken to 
enable the team to dissect a patient’s journey by utilizing tools 
for modernizing services and data collected from complaints 
from patients, staff, and incident reports.
Process mapping
The currently existing care process was described. The team 
analyzed where the problems exist throughout the process 
and questioned who, where, and in what sequence each step 
is performed, all the while asking if there was a better way 
to achieve the same goal.
The exercise aimed to identify the following:
Claims: What factors made the group collectively proud of 
the team and the service they provide?
Concerns: What aspects of the service they provide were the 
most concerning?
Issues: Any other concerns they shared.
Members of the group represented expertise in each phase 
of the process, and a forum was established to encourage 
honesty and the sharing of issues without the fear of blame. 
The chemotherapy process was examined from referral to 
the completion of treatment. Hotspots were highlighted, 
and a proactive approach was taken for all issues related to 
chemotherapy.
What factors made the group collectively proud of the 
team and the service they provide?
•	 The morale of the staff is good and the service provided 
is praised by patients and relatives
•	 Staff felt that the actual location where chemotherapy is 
administered is of a high standard
•	 The environment where care is provided is pleasant and 
fit for its purpose
•	 Excellent information is available for patients
•	 There is an excellent multidisciplinary team spirit and 
open communication
What aspects of the service they provide were most 
concerning?
•	 Aspects of the chemotherapy prescription process
•	 The referral process from the multidisciplinary team is not 
always clear, and communication could be improved
•	 Staffing issues for therapy input meant that no cover is 
available on some days and this problem is exacerbated 
by short notices
•	 Prescription requests from the pharmacy are sometimes 
made on the same day as treatment. Medical staff are 
frequently too busy on the day of treatment to complete 
prescriptions, and notes are often unavailable. This 
increases the risk of a clinical incident and often means 
that patients have to wait for treatment
•	 At certain points in the chemotherapy process, commu-
nication is an issue
•	 Concerns were raised about drugs being administered 
without medical coverage
•	 Doctors frequently prescribe repeat chemotherapy with-
out patient notes
•	 OPMAS (Oncology Patient Management Audit System) 
use is not maximized by all who have access and that 
includes doctors in clinics and nurses on the chemo-
therapy day unit
Identified hand-offs and key issues
•	 Hand-offs when the patient’s care is transferred from one 
area to another individual or team
•	 Issues regarding the availability of beds for emergency 
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•	 Consultants are often waiting up to two weeks for beds
•	 The number of review slots in clinics
•	 Staffing levels in all departments
•	 A lack of uniformity in the way consultants document 
the treatment plan
•	 Patients arriving for treatment with no prescription 
sheet
•	 No formalized structure for weighing patients on 
  chemotherapy was in place
•	 Overbooking
•	 Concerns about capacity in the same-day unit
•	 Bank holidays
•	 Delays in obtaining blood tests before treatment
•	 The medical review process is not uniform
•	 Issues with the contribution of palliative care and social 
service teams
•	 Upon finishing therapy, no routine support group 
access
Key measures for improvement
Following discussion, it was evident that there were missing 
links and a lack of consistency between departments. As a 
result of the analysis, some recommendations were made, 
including the following:
a.    There is a need for a better link between the medical staff, 
the pharmacy, and the chemotherapy day unit. The chemo-
therapy lead nurse has the role within the chemotherapy 
service to link patient’s complaints with the chemotherapy 
process. Having fewer people involved reduces risk as 
well as developing the role of the chemotherapy services 
clerk whose role includes ensuring that prescriptions are 
organized and completed before the patient attends the day 
unit and ensuring that blood results are available before 
treatment is administered. That person would also act as a 
link between the different groups involved in the process 
and improve communication between the professionals 
involved in the process of chemotherapy treatment from 
first consultation with the doctor to the administration of 
the treatment.4–6
b.    Benchmarking against other tertiary cancer centers to 
ascertain chemotherapy practices and to highlight best 
practices, taking into consideration local and national 
guidance.
c.    Extending the usage of for information purposes and to 
improve communication.
d.    Standard chemotherapy referral forms are completed by 
the oncologist who examined the patient. This includes 
which chemotherapy to use, the number of cycles, 
the frequency of blood tests and scans, and medical 
comments.
e.    Weight forms. Patients are now being weighed in the 
chemotherapy day unit or outpatient   departments. This 
only highlights a patient who has lost more than 10% of 
their original weight.
f.    A patient information support group with contact 
numbers for patients who had previously received 
chemotherapy.
Developments and outcomes 
achieved
Referral form
An intent to treat form was devised, and this form was tested 
using the Plan Do Study Act (PDSA) cycle. Initially, three 
consultants were involved in testing the feasibility of the 
introduced form. Gradually, the forms were introduced to 
the rest of the team and they are now used by all consultants 
and junior doctors in all clinics at the cancer center and 
peripheral clinics. The compliance of form use has been 
audited, and the results demonstrate a gradual increase in the 
use over the last few months from 84% in January 2006 to 
100% in May 2006. This high level of compliance has been 
maintained to date.
Having the treatment plan accessible to all staff has 
reduced errors, and Figure 1 demonstrates the improvements 
in the chemotherapy process as a result of the changes made 
in the practice.
In 2004, the number of incident reports (IR1s) was 
low, but upon reflection, this finding was due to the 
lack of practice reporting problems in the chemotherapy 
process by IR1s. As more problems were noticed in 
2005, the trend shifted towards the department reporting 
  chemotherapy problems so that they could be addressed. 
These   problems  included  late  prescriptions,  dose 
  reductions not noted in the records, and problems with 
  chemotherapy   prescriptions. The reduction of IR1s through 
the end of 2005 and 2006 reflected the   improvement in the 
  chemotherapy process achieved by the referral form, 
the better   communication, and the systems set up by the 
  Chemotherapy   Improvement Group.
Chemotherapy administration clerk
This position was created to provide a missing link within 
the department. This new position has improved all the 
processes involved in chemotherapy administration. The 
chemotherapy administration clerk’s roles include ensuring 
prescription requests are more organized and having blood Risk Management and Healthcare Policy 2011:4 submit your manuscript | www.dovepress.com
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results available the day before patients are treated, thereby 
enabling the preordering of chemotherapy, which reduces 
the wait times for patients. Having fewer people involved 
in the process ultimately reduces the risk throughout the 
chemotherapy process. In addition, communication among 
all departments has improved.
Weight forms
The weight forms were examined because patients were not 
being weighed at any particular time. This was flagged as 
a risk because the pharmacy was not being informed when 
patients had lost or gained 10% or more of their weight at 
their first treatment. Dose reductions were not performed due 
to this lack of information.
Subsequently, a decision by the group was made to weigh 
patients at every clinic or chemotherapy day-case unit visit 
if the patient had not been seen at the outpatient department. 
Every patient is now weighed at least once a month. The Trust 
weight chart was introduced and placed in the clinical notes 
section of the chart, and a process has been enabled to inform 
the appropriate departments when necessary. The pharmacy is 
contacted if a patient’s weight changes by more than 10%.
An audit of compliance with the weight forms in May 
2006 was 85%, which represented an increase of 5% 
  compared with a previous audit in March of the same year. 
This audit will be repeated again in April 2007 and will 
  hopefully demonstrate a further increase in compliance.
Patient information group
It was highlighted by the staff and the patient   representative that 
there is a lack of support for patients when their   chemotherapy 
treatment has finished. The intention of this group was to 
produce a leaflet for patients for after   treatment informing 
them of support groups and containing contact numbers. 
The Chemotherapy Improvement Group is also examining 
an “exit” assessment that incorporates the   Chemotherapy 
Common Toxicity Criteria so the nurse can address any issues 
and refer to other specialists as appropriate.
Conclusion
The chemotherapy service is integral in the delivery of onco-
logic management at the North Wales Cancer Centre. When 
a potential risk was identified, it was essential to find the root 
cause and improve the system. By promoting a clear vision 
for the group and the identified structure (ie, Risk Manage-
ment and Safer Patient Group), members were focused on 
the objectives. The risks were assessed, and the information 
was collated from all areas and disciplines involved in the 
process (patients, doctors, nurses, clerks, pharmacists, etc). 
By utilizing methods of modernization tools, several recom-
mendations were made including the following:
The need for a link between medical staff, the pharmacy, 
and the chemotherapy day unit, a defined role of chemo-
therapy services clerk, and a standardized chemotherapy 
referral form.
Two new positions were developed to create a smoother 
process for chemotherapy treatment. The purpose of the 
chemotherapy services clerk is to bridge the gaps identified 
in the process. The other position incorporates the knowledge 
and skills of an experienced nurse by establishing a single 
focus for the division and examining the service development 
of different aspects for chemotherapy.
This group resulted in a sense of direction and knowledge 
about what we were aiming to achieve. These improvements 
in the service were a result of the multidisciplinary approach 
and commitment of the Chemotherapy Improvement Group, 
and although it was not the primary intention of this analysis, 
the implications of the Hospice care for these patients was 
also considered, but on further reflection, it was decided 
that this issue deserves separate consideration and it will be 
a theme of future research in our unit.
0
5
10
15
20
25
N
u
m
b
e
r
 
o
f
 
I
R
1
s
Jan
Mar
May
Jul
Sep
Nov
2004 2005 2006
Month/year
Figure 1 Improvements in the chemotherapy process.Risk Management and Healthcare Policy
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We hope to use these findings to plan future studies   looking 
into risk management issues in this group of patients.
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